The Lancet Gastroenterology & Hepatology

Title Publication Date Language Citations
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis2017/10/01English11
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial2016/11/01English10
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis2021/08/01English10
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial2021/07/01English10
The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment2019/08/01English10
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172020/06/01English10
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192022/09/01English10
Pathophysiology of irritable bowel syndrome2016/10/01English10
Implications of COVID-19 for patients with pre-existing digestive diseases2020/05/01English10
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172019/12/01English10
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study2020/03/01English9
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial2018/05/01English9
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis2017/07/01English9
Detection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study2020/04/01English9
Current and potential treatments for primary biliary cholangitis2020/03/01English9
A global scientific strategy to cure hepatitis B2019/07/01English9
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192022/07/01English8
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial2018/01/01English8
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission2019/02/01English8
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials2018/04/01English8
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa2021/01/01English8
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study2021/10/01English8
Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study2019/08/01English8
Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study2020/04/01English8
Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study2018/04/01English8
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review2022/04/01English7
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west2019/09/01English7
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study2019/09/01English7
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial2022/01/01English7
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial2017/04/01English7